EIF4A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.405400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.685200E-01
Normal-vs-Stage2
5.056800E-01
Normal-vs-Stage3
1.217590E-01
Normal-vs-Stage4
4.471800E-01
Stage1-vs-Stage2
4.634800E-01
Stage1-vs-Stage3
2.266500E-02
Stage1-vs-Stage4
1.677350E-01
Stage2-vs-Stage3
1.784780E-01
Stage2-vs-Stage4
6.041500E-02
Stage3-vs-Stage4
1.506000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.473200E-01
Normal-vs-AfricanAmerican
4.338000E-01
Normal-vs-Asian
5.649400E-01
Caucasian-vs-AfricanAmerican
5.735600E-01
Caucasian-vs-Asian
6.040600E-01
AfricanAmerican-vs-Asian
8.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.456000E-01
Normal-vs-Female
6.440600E-01
Male-vs-Female
9.196600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.419600E-01
Normal-vs-Age(41-60Yrs)
9.725000E-01
Normal-vs-Age(61-80Yrs)
5.321600E-01
Normal-vs-Age(81-100Yrs)
5.330800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.987200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.655600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.588000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.483750E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.773620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.824200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.904240E-01
Normal-vs-Daily Drinker
1.989210E-01
Normal-vs-Weekly Drinker
9.267900E-02
Normal-vs-Occasional Drinker
5.226600E-01
Normal-vs-Social Drinker
9.408600E-01
Non Drinker-vs-Daily Drinker
8.088600E-01
Non Drinker-vs-Weekly Drinker
1.510950E-01
Non Drinker-vs-Occasional Drinker
3.520700E-03
Non Drinker-vs-Social Drinker
1.068560E-01
Daily Drinker-vs-Weekly Drinker
2.677800E-01
Daily Drinker-vs-Occasional Drinker
3.024900E-03
Daily Drinker-vs-Social Drinker
6.608100E-02
Weekly Drinker-vs-Occasional Drinker
1.077010E-03
Weekly Drinker-vs-Social Drinker
2.144300E-02
Occasional Drinker-vs-Social Drinker
1.905400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.543700E-02
Normal-vs-Grade 2
7.639400E-04
Normal-vs-Grade 3
1.717540E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.697800E-01
Grade 1-vs-Grade 3
7.770200E-01
Grade 1-vs-Grade 4
7.543700E-02
Grade 2-vs-Grade 3
2.405800E-01
Grade 2-vs-Grade 4
7.639400E-04
Grade 3-vs-Grade 4
1.717540E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.098400E-01
Normal-vs-NonDiabetic
7.025800E-01
Diabetic-vs-NonDiabetic
1.089040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.629200E-01
Normal-vs-NoPancreatitis
6.402400E-01
Pancreatitis-vs-NoPancreatitis
3.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.377400E-01
Normal-vs-N1
4.511400E-01
N0-vs-N1
1.050370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.779000E-01
Normal-vs-TP53-NonMutant
8.234000E-01
TP53-Mutant-vs-TP53-NonMutant
1.945760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
